Harpreet Singh

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 29

Top Topics

Myasthenia Gravis

Drug Administration

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for locally advanced or metastatic ROS1-positive non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Sonia Singh, Diana Bradford, Xiaoxue Li, Pallavi S Mishra-Kalyani, Yuan Li Shen, Lingshan Wang, Hong Zhao, Ye Xiong, Jiang Liu, Rosane Charlab, Jeffrey Kraft, Sachia Khasar, Claudia P Miller, Donna R Rivera, Paul G Kluetz, Richard Pazdur, Julia A Beaver, Harpreet Singh, Martha Donoghue
FDA Approval Summary: Alpelisib for PIK3CA-related Overgrowth Spectrum (PROS). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michael I Barbato, Jeannette Nashed, Diana Bradford, Yi Ren, Sachia Khasar, Claudia P Miller, Banu S Zolnik, Hong Zhao, Yangbing Li, Youwei Bi, Stacy S Shord, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Raniya A Al-Matari, Richard Pazdur, Paul G Kluetz, Martha Donoghue, Harpreet Singh, Nicole Drezner
FDA Approval Summary: Dabrafenib in combination with trametinib for BRAF V600E mutation-positive low-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Luckson N Mathieu, Erin Larkins, Arup K Sinha, Pallavi S Mishra-Kalyani, Samina Jafri, Shyam Kalavar, Soma Ghosh, Kirsten B Goldberg, Richard Pazdur, Julia A Beaver, Harpreet Singh
FDA Approval Summary: Atezolizumab as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Katie Chon, Erin Larkins, Somak Chatterjee, Pallavi S Mishra-Kalyani, Stephanie L Aungst, Emily Wearne, Sriram Subramaniam, Yangbing Li, Jiang Liu, Jielin Sun, Rosane Charlab, Hong Zhao, Banu Saritas-Yildirim, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Julia A Beaver, Harpreet Singh
FDA Approval Summary: Amivantamab for the Treatment of patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the treatment of advanced RET fusion-positive solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Liza Stapleford, Nicole Drezner, Anup K Amatya, Pallavi S Mishra-Kalyani, Yuan Li Shen, Kimberly Maxfield, Jeanne F Zirkelbach, Youwei Bi, Jiang Liu, Xinyuan Zhang, Hezhen Wang, Yuching Yang, Nan Zheng, Kelie Reece, Emily Wearne, Jacqueline J Glen, Idara Ojofeitimi, Barbara Scepura, Abhilasha Nair, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Richard Pazdur, Julia A Beaver, Harpreet Singh, Martha Donoghue
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)